%20--%3e%3csvg%20width='63.297821mm'%20height='39.29665mm'%20viewBox='0%200%2063.297821%2039.29665'%20version='1.1'%20id='svg8765'%20inkscape:version='1.1%20(c4e8f9ed74,%202021-05-24)'%20sodipodi:docname='OBALogoSingle2.svg'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview8767'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:pageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:document-units='mm'%20showgrid='false'%20fit-margin-top='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-bottom='0'%20inkscape:zoom='1.1759259'%20inkscape:cx='179.85827'%20inkscape:cy='102.04724'%20inkscape:window-width='1920'%20inkscape:window-height='972'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs8762'%20/%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%20transform='translate(-31.351095,-50.101677)'%3e%3cpath%20style='fill:none;stroke:%233584e4;stroke-width:3.965;stroke-linecap:square;stroke-linejoin:round;stroke-miterlimit:4;stroke-dasharray:none;stroke-opacity:1'%20d='m%2077.07508,77.78787%2014.84134,8.87817%20V%2052.83397%20L%2034.08359,86.5521%20V%2053.69366%20l%2015.27351,9.31107'%20id='path8388'%20sodipodi:nodetypes='cccccc'%20/%3e%3c/g%3e%3c/svg%3e)
Johnson & Johnson(JNJ) Stock Analysis | Healthcare
Market Performance
Stock returned +10.0% over the past year, broadly in line with market conditions.Analyst Target
Analyst consensus price target: $272.50.What is Johnson & Johnson?
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
JNJ · Verdict
Solid reward · low risk
JNJ stands out on volatility and cash flow, but watch the valuation signal.
Based on 88% data coverage
JNJ · Verdict
What’s working & what to watch
Strengths 4
- Volatility95/100
Top decile vs peers
- Cash flow92/100
21% free-cash-flow margin
- Profitability87/100
28% net margin · 26% ROE
- Balance sheet69/100
Interest covered 34.6×
Watchouts 1
- Valuation26/100
P/E 23.2× · PEG 4.73
Model-based scoring. For information only — not financial advice.
What is Johnson & Johnson?
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 651.25B, and a P/E ratio of 31.4x.
Financial Highlights
Investment Breakdown
Analysis
Reward: Moderate (56)The scoring profile indicates moderate reward potential, with profitability and growth as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.
For informational purposes only. Not financial advice.
Similar stocks to compare
A short list of Drug Manufacturers - General names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 330,142 shares $7.4M | 0 |
| 9-12months | 0 | 0 |
Openbook research
Latest analysis
Trading 212 Dividend Tracker: Track Your Income
Learn how to export Trading 212 data as a CSV, track dividend income in a spreadsheet, and use the Trading 212 API to automate your dividend tracking workflow.
How to Research a Stock: A Step-by-Step Process - 2026
Learn the best way to research stocks with a clear, step-by-step investment research workflow — from defining your criteria to valuation and choosing the right stock research tools.
What Is a Financial Analytics Dashboard? A UK Guide
A financial analytics dashboard consolidates portfolio data, market metrics, and performance insights into one visual interface. This guide explains what these dashboards do, what features matter most, and which financial analytics dashboard tools are best suited to different types of investors.